Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Receivables (2016 - 2025)

Historic Receivables for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to $6.0 million.

  • Ekso Bionics Holdings' Receivables fell 1315.34% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year decrease of 1315.34%. This contributed to the annual value of $7.2 million for FY2024, which is 2821.97% up from last year.
  • Ekso Bionics Holdings' Receivables amounted to $6.0 million in Q3 2025, which was down 1315.34% from $4.5 million recorded in Q2 2025.
  • Ekso Bionics Holdings' 5-year Receivables high stood at $7.2 million for Q1 2024, and its period low was $2.3 million during Q1 2021.
  • In the last 5 years, Ekso Bionics Holdings' Receivables had a median value of $4.8 million in 2023 and averaged $4.9 million.
  • Its Receivables has fluctuated over the past 5 years, first skyrocketed by 7283.7% in 2023, then crashed by 3047.55% in 2025.
  • Ekso Bionics Holdings' Receivables (Quarter) stood at $4.7 million in 2021, then dropped by 0.79% to $4.6 million in 2022, then grew by 22.05% to $5.6 million in 2023, then grew by 28.22% to $7.2 million in 2024, then dropped by 16.44% to $6.0 million in 2025.
  • Its Receivables stands at $6.0 million for Q3 2025, versus $4.5 million for Q2 2025 and $6.5 million for Q1 2025.